Citadel Advisors’s AlphaClone International ETF ALFI Stock Holding History

Citadel Advisors’s Portfolio ALFI Stock Details ALFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-19,868	Closed	-$455K	–	8577
2017 Q2	$455K	Sell	19,868 -5,188	-21%	-$116K	﹤0.01%	5261
2017 Q1	$532K	Sell	25,056 -13,467	-35%	-$273K	﹤0.01%	4916
2016 Q4	$739K	Buy	38,523 +1,341	+4%	+$26.6K	﹤0.01%	4299
2016 Q3	$771K	Buy	+37,182	New	+$755K	﹤0.01%	4185

Other funds holding ALFI

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Citadel Advisors's ALFI Position: Q3 2017 in Review

Citadel Advisors sold out of AlphaClone International ETF (ALFI) in Q3 2017, closing a stake of 19,868 shares — an estimated $455K sold.

Citadel Advisors first reported a position in ALFI in Q3 2016 and held it in 4 quarters. The position peaked at $771K in Q3 2016. 2 funds tracked by Wall St. Rank hold ALFI as of Q3 2017.

Citadel Advisors reported no remaining AlphaClone International ETF position as of Q3 2017 after selling out during the quarter.
Citadel Advisors sold 19,868 AlphaClone International ETF shares in Q3 2017, an estimated $455K.
Citadel Advisors first reported a position in AlphaClone International ETF in Q3 2016 and held it in 4 quarters.
Citadel Advisors's AlphaClone International ETF position peaked at $771K in Q3 2016.
2 funds tracked by Wall St. Rank held AlphaClone International ETF as of Q3 2017.

Based on Citadel Advisors's 13F filing for Q3 2017, filed 9 Nov 2017.